<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.theedgeresearch.com/news</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-03</news:publication_date>
      <news:title>U.S. Services-Sector Activity Expanded Again in August</news:title>
    </news:news>
    <lastmod>2026-09-03</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/TFC</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-03</news:publication_date>
      <news:title>TFC Still Trails Its 2019 Merger Targets: Can the New CEO Change That?</news:title>
    </news:news>
    <lastmod>2026-09-03</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/ONON</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-03</news:publication_date>
      <news:title>Can ONON&apos;s Higher 2026 Margin Outlook Offset Tariff and Sales Risks?</news:title>
    </news:news>
    <lastmod>2026-09-03</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/ACRV</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-03</news:publication_date>
      <news:title>Acrivon Therapeutics, Inc. (ACRV) Just Flashed Golden Cross Signal: Do You Buy?</news:title>
    </news:news>
    <lastmod>2026-09-03</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/NVDA</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-03</news:publication_date>
      <news:title>Wall Street Analysts See a 44.63% Upside in Nvidia (NVDA): Can the Stock Really Move This High?</news:title>
    </news:news>
    <lastmod>2026-09-03</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/ACMR</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-03</news:publication_date>
      <news:title>ACM Research (ACMR) May Find a Bottom Soon, Here&apos;s Why You Should Buy the Stock Now</news:title>
    </news:news>
    <lastmod>2026-09-03</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/NUVB</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-03</news:publication_date>
      <news:title>Does Nuvation Bio (NUVB) Have the Potential to Rally 91.92% as Wall Street Analysts Expect?</news:title>
    </news:news>
    <lastmod>2026-09-03</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/GGG</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-03</news:publication_date>
      <news:title>Graco (GGG) Could Find a Support Soon, Here&apos;s Why You Should Buy the Stock Now</news:title>
    </news:news>
    <lastmod>2026-09-03</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/FIGR</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-03</news:publication_date>
      <news:title>Does Figure Technology (FIGR) Have the Potential to Rally 53.96% as Wall Street Analysts Expect?</news:title>
    </news:news>
    <lastmod>2026-09-03</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/ACET</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-03</news:publication_date>
      <news:title>Wall Street Analysts See a 258.21% Upside in Adicet Bio (ACET): Can the Stock Really Move This High?</news:title>
    </news:news>
    <lastmod>2026-09-03</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/RBC</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-03</news:publication_date>
      <news:title>RBC Bearings (RBC) Could Find a Support Soon, Here&apos;s Why You Should Buy the Stock Now</news:title>
    </news:news>
    <lastmod>2026-09-03</lastmod>
  </url>
</urlset>
